Moles

AMERICAN ACADEMY OF DERMATOLOGY SURVEY SHOWS OUTDOOR WORKERS MORE AT RISK FOR SKIN CANCER THAN AVERAGE AMERICANS

Retrieved on: 
星期二, 五月 7, 2024

ROSEMONT, Ill., May 7, 2024 /PRNewswire/ -- A recent American Academy of Dermatology survey of more than 1,000 U.S. adults revealed that outdoor workers – like those who work in construction, landscaping, emergency medical services, and postal delivery – are far more likely to get sunburned and tanned, putting themselves at increased risk for skin cancer, compared to the average American. In recognition of Skin Cancer Awareness Month this May, the AAD encourages everyone – and especially those who work outdoors – to practice safe sun to protect themselves from the sun's harmful rays and reduce their risk of developing skin cancer.

Key Points: 
  • According to the survey, half of outdoor workers were sunburned in 2023, compared to 36 percent reported by the general American population.
  • One in 10 outdoor workers had sunburns severe enough to cause blisters, a rate double that of the general population.
  • And nearly 80 percent of outdoor workers got a tan or darker skin as a result of sun exposure, compared to 67 percent of Americans overall.
  • Tanning and unprotected sun exposure are major risk factors for skin cancer, the most common form of cancer in the United States and one of the most preventable types of cancer.

Melanoma Research Alliance Announces $12.6 Million Investment in Cutting Edge Melanoma Research

Retrieved on: 
星期三, 五月 1, 2024

WASHINGTON, May 1, 2024 /PRNewswire/ -- The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at leading academic and medical institutions in the United States and across the globe.

Key Points: 
  • WASHINGTON, May 1, 2024 /PRNewswire/ -- The Melanoma Research Alliance (MRA), the world's leading non-profit funder of melanoma research, announced its $12.6 million commitment to fund melanoma research supporting more than 30 scientists at leading academic and medical institutions in the United States and across the globe.
  • "When MRA was founded in 2007, melanoma research was stagnant and treatment options were few.
  • "Melanoma research has made tremendous progress over the last 15 years," said MRA Chief Science Officer Joan Levy, PhD.
  • MRA's investments in rare melanoma research have begun to advance the field's understanding of the biology of these rare melanomas and their molecular differences from cutaneous (skin) melanoma.

Tenayo Foods Unveils Vibrant New Line Of Sauces Designed To Globalize the American Pantry

Retrieved on: 
星期三, 五月 1, 2024

BOULDER, Colo., May 1, 2024 /PRNewswire/ -- Tenayo Foods, a premium provider of gourmet, Mexican-style sauces, proudly announces the launch of its new Barbecue and Mole Sauces, marking a significant milestone in the company's journey of culinary excellence. This line extension and website relaunch reflect Tenayo's unwavering dedication to delivering flavor and innovation to its customers. Inspired by the rich tapestry of Mexican culture and cuisine, the new line of sauces captures Tenayo's commitment to making bold flavor experiences approachable for everyone, every day.

Key Points: 
  • This line extension and website relaunch reflect Tenayo's unwavering dedication to delivering flavor and innovation to its customers.
  • Inspired by the rich tapestry of Mexican culture and cuisine, the new line of sauces captures Tenayo's commitment to making bold flavor experiences approachable for everyone, every day.
  • "An intensely flavorful sauce can transform an entire meal," said Lonna Borden and Seth Monette, co-CEOs of Tenayo Foods.
  • For more information about Tenayo and find a retailer near you, please visit https://tenayofoods.com/ or follow the brand's journey at @tenayofoods .

Dermatology Imaging Devices Market Sees Strong 13% CAGR (2024-2030), Propelled by Rising Skin Cancer Cases

Retrieved on: 
星期三, 三月 13, 2024

The global dermatology imaging devices market size is anticipated to reach USD 5.60 billion by 2030 and it is projected to grow at a CAGR of 13.09% from 2024 to 2030.

Key Points: 
  • The global dermatology imaging devices market size is anticipated to reach USD 5.60 billion by 2030 and it is projected to grow at a CAGR of 13.09% from 2024 to 2030.
  • The growing prevalence of skin disorders such as cancer, and inflammatory dermatoses, among others are the major contributing factors for market growth.
  • Dermatology imaging devices are efficient as they provide non-invasive, high-resolution visualization of skin lesions and other related conditions.
  • Technological advancements in dermatology imaging devices such as high-resolution images, integration with AI, 3D imaging are further expected to contribute to the market growth.

La Jolla Vein & Vascular Adds New Medical Specialty; Opens Dermatology Clinic in Vista

Retrieved on: 
星期四, 二月 15, 2024

La Jolla Vein & Vascular adds new specialist to offer dermatology services in Vista.

Key Points: 
  • La Jolla Vein & Vascular adds new specialist to offer dermatology services in Vista.
  • The dermatology clinic is set to open in March, and is located at 906 Sycamore Ave, Suite 100, Vista, California.
  • View the full release here: https://www.businesswire.com/news/home/20240215088694/en/
    Dr. Heidi Busch, a board-certified dermatologist joins La Jolla Vein & Vascular to spearhead their expansion of services with a new Medical and Cosmetic Dermatology clinic in Vista, California.
  • To schedule a consultation with Dr. Busch, call 760-249-7007 or learn more about La Jolla Vein & Vascular’s services at www.ljvascular.com .

FDA Clearance Granted for First AI-Powered Medical Device to Detect All Three Common Skin Cancers (Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma)

Retrieved on: 
星期三, 一月 17, 2024

Better identifying skin cancer in a primary care setting is designed to accelerate patient access to necessary care.

Key Points: 
  • Better identifying skin cancer in a primary care setting is designed to accelerate patient access to necessary care.
  • The good news is that 99 percent of skin cancers, including the most deadly form, melanoma, are curable if detected early.
  • The company has conducted 13 clinical studies in the last decade, six of which provided the principal support for FDA clearance.
  • Clinical Utility of an Elastic Scattering Spectroscopy Device in Assisting Primary Care Physician’s Detection of Skin Cancers.

Orlucent Demonstrates Accurate, Non-Invasive Detection in vivo of Melanoma-Related Activity Using First-in-Kind Handheld Mole Imaging System

Retrieved on: 
星期二, 一月 16, 2024

With the current standard of care, melanoma is identified in suspicious nevi using subjective visual clinical evaluations, during which the color, shape, and size of nevi are assessed using the ABCDE criteria (asymmetry, border, color, diameter, and evolution). When moles exhibit only one or two of these atypical features, discerning whether they could develop into melanoma becomes arduous. To avoid missing a melanoma, dermatologists rely on "when in doubt, cut it out" to manage moles which do not overtly classify as melanoma or benign -- the "grey area" lesions -- resulting in unnecessary biopsies, scarring and patient anxiety.

Key Points: 
  • Melanoma, the most lethal form of skin cancer, has long been a challenge to detect accurately, particularly those cases with the potential for aggressive behavior.
  • When moles exhibit only one or two of these atypical features, discerning whether they could develop into melanoma becomes arduous.
  • Encouraged by these findings, Orlucent is continuing research of mSFI and is preparing for FDA submission.
  • The peer-reviewed article in Pigment Cell and Melanoma Research is titled, "Molecular Skin Fluorescence Imaging: A Tool for Evaluating Early Melanoma Development," and can be found at http://doi.org/10.1111/pcmr.13159 .

Thinking of a(nother) tattoo this summer? What you need to know about sunburn, sweating and fading

Retrieved on: 
星期六, 十二月 30, 2023

More of us have tattoos than ever before. About 25% of Australians are inked. A tattoo can be a large investment in time, money and pain. So how do you take care of your tattooed skin? Here’s what you need to know about sunburn, sweating and fading.

Key Points: 


More of us have tattoos than ever before. About 25% of Australians are inked. A tattoo can be a large investment in time, money and pain. So how do you take care of your tattooed skin? Here’s what you need to know about sunburn, sweating and fading.

Read more:
Tattoos have a long history going back to the ancient world – and also to colonialism

What’s a tattoo, dermatologically speaking?


Tattoo inks are deposited in the layer of skin called the dermis. This layer contains sweat and oil glands, a blood supply, immune cells, collagen to support the skin’s structures, and fibroblasts, which produce collagen.
Fibroblasts take up the ink particles, as do immune cells in the dermal tissue known as macrophages. The ink particles also stick inside bundles of collagen. Between these three mechanisms, the dermis holds tattoo inks so well they can be seen even on the 5,300-year-old ice mummy Ötzi.

Read more:
What Ötzi the prehistoric iceman can teach us about the use of tattoos in ceremonial healing or religious rites

Can I get a tattoo if I’m sunburnt?

  • During sunburn, your skin calls in extra immune cells and fluid to kill off and break down cells that have too much UV damage.
  • This inflammation can affect the tattoo ink deposits.

How soon after my new tattoo can I go into the sun?


There’s not much research on how soon you can expose your new tattoo to the sun. However, most tattooists advise you to avoid sun exposure while the tattoo heals, generally about three weeks. This seems sensible, as your fresh tattoo is a type of wound.

  • There is an influx of immune cells to deal with the damage, much like a sunburn.
  • So, in one way, you should treat your new tattoo like sunburn and avoid sun exposure while it heals.
  • But you shouldn’t use sunscreen on the tattoo in that time.

What happens if my tattoo gets sunburnt?

  • There’s usually swelling, itching or stinging on the tattoo site that can start immediately or develop over the course of a day.
  • There is also a small amount of evidence that sunburn on a tattoo temporarily suppresses the skin’s immune system, allowing an infection to become established.

Do tattoos increase my risk of skin cancer?

  • However, there’s no evidence skin cancers are more likely in tattooed skin.
  • Tattoos make newly-developed skin cancers more difficult to detect.
  • Red tattoos seem to be more prone to large but benign (non-cancerous) skin tumours called keratoacanthomas.
  • However, they can be difficult to distinguish from squamous cell carcinomas (a type of skin cancer).

Can sunlight fade my tattoo?

  • As tattoos age, they can fade a bit as some of the loose ink particles filter deeper into the dermis.
  • Sun exposure can also degrade ink particles.
  • After all, most people don’t want to fade their tattoos for science.

Does tattooed skin sweat differently to un-inked skin?

  • If you’ve got a full sleeve or your whole back is your canvas, that’s a significant amount of skin.
  • Since tattooing punctures the skin repeatedly, sweat glands in the dermis may be damaged.
  • However, when other researchers looked at sweating induced by exercise there was no effect in the volume of sweat between tattooed and un-tattooed skin.

Longer-term risks


When performed under the clean conditions of a licenced tattoo parlour, tattooing is relatively safe. But long term, some people develop allergic reactions to certain colours due to the different compounds in each, most commonly red dyes. This can cause lumps, scales, scarring or other visible changes. So, what’s the most common long-term side effect of tattoos? Tattoo regret and wanting to have them removed.
Katie Lee receives funding from the National Health and Medical Research Council. Erin McMeniman does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Skin Cancer and Reconstructive Surgery Center of California Adopts AI-driven Nevisense for early skin cancer detection

Retrieved on: 
星期一, 十二月 4, 2023

The Nevisense System is a first-of-its-kind AI-driven technology that uniquely addresses the complexities of point-of-care detection of the deadliest form of skin cancer by providing clinicians with advanced analysis of irregular moles during routine skin checks.

Key Points: 
  • The Nevisense System is a first-of-its-kind AI-driven technology that uniquely addresses the complexities of point-of-care detection of the deadliest form of skin cancer by providing clinicians with advanced analysis of irregular moles during routine skin checks.
  • Dr. Madorsky is also the CME Chair of the SCARS Foundation, dedicated to skin cancer research and physician education.
  • "At SCARS Center, we are dedicated to providing our patients and physicians with the resources needed to understand, prevent, and cure skin cancers.
  • Early detection of skin cancers with advanced technology provides patients with the peace of mind they deserve during skin cancer checks," said Dr. Madorsky.

Skin Cancer and Reconstructive Surgery Center of California Adopts AI-driven Nevisense for early skin cancer detection

Retrieved on: 
星期一, 十二月 4, 2023

The Nevisense System is a first-of-its-kind AI-driven technology that uniquely addresses the complexities of point-of-care detection of the deadliest form of skin cancer by providing clinicians with advanced analysis of irregular moles during routine skin checks.

Key Points: 
  • The Nevisense System is a first-of-its-kind AI-driven technology that uniquely addresses the complexities of point-of-care detection of the deadliest form of skin cancer by providing clinicians with advanced analysis of irregular moles during routine skin checks.
  • Dr. Madorsky is also the CME Chair of the SCARS Foundation, dedicated to skin cancer research and physician education.
  • "At SCARS Center, we are dedicated to providing our patients and physicians with the resources needed to understand, prevent, and cure skin cancers.
  • Early detection of skin cancers with advanced technology provides patients with the peace of mind they deserve during skin cancer checks," said Dr. Madorsky.